RCE 1.56% 65.0¢ recce pharmaceuticals ltd

Ann: Update on Phase I/II Clinical Trial for Burn Wound Infection, page-2

  1. 5,232 Posts.
    lightbulb Created with Sketch. 679
    Only read top lines but Yess yes yes lol. Great looking and have been desperately looking forward to

    Highlights:• Broad spectrum antibiotic activity on bacterial Burn Wound infections withvisible infection reduction <24 hours on all patients to date• All infections cleared within 5 days (acute) or 7 days (chronic); clinicians reducing treatment windows per protocol/positive patient indications• Burn wound infections consisted of Gram-positive and Gram-negative bacteria, including multi-drug resistant and ‘biofilm’ categorised forms• Update in-line with reaching clinical trial end-points; patient recruitment ongoing
 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
(20min delay)
Last
65.0¢
Change
0.010(1.56%)
Mkt cap ! $132.5M
Open High Low Value Volume
64.5¢ 65.5¢ 64.5¢ $26.17K 40.36K

Buyers (Bids)

No. Vol. Price($)
2 10615 65.0¢
 

Sellers (Offers)

Price($) Vol. No.
65.5¢ 6974 1
View Market Depth
Last trade - 16.10pm 13/05/2024 (20 minute delay) ?
Last
65.0¢
  Change
0.010 ( 1.56 %)
Open High Low Volume
65.0¢ 65.5¢ 65.0¢ 1745
Last updated 14.58pm 13/05/2024 ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.